JCHO Tokyo Yamate Medical Center

Tokyo 169-0073

1 studies enrolling now · 4 studies all time

What they study most

Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Short Bowel Syndrome

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. — Running, not enrolling
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed